ANT-INTERNATIONAL
27.6.2024 07:12:29 CEST | Business Wire | Press release
On 2024 International MSME Day, Ant International, a digital payment and financial services leader, shares that it supports almost 100 million Micro, Small, and Medium-sized Enterprises (MSMEs) worldwide across its businesses and partner programs; and reinforces its commitments towards MSME digitalization and inclusion through the expansion of its services, new programs for skills development with industry partners, and a new global campaign.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626356788/en/
(Photo: Business Wire)
“MSMEs are the lifeblood of our economies, driving innovation, employment, and inclusive development,” said Douglas Feagin, President of Ant International. “Their resilience and entrepreneurial spirit deserve to be celebrated and nurtured. At Ant International, we firmly believe in the power of small and that small businesses can make a big impact. Fintech innovations today unlock new possibilities for small businesses to dream boldly and compete globally. Together with our partners, we want to ensure that every business and every person will have access to the knowledge, network, and digital tools to help them achieve their goals.”
Empowering growth for MSMEs through digitalization
Across its businesses, Ant International offers solutions that enable MSMEs to digitalize, opening new growth opportunities.
Alipay+, the cross-border mobile payments and marketing solutions operated by Ant International, announced an expansion of its global acceptance. As of June 2024, Alipay+ is accepted by over 90 million merchants in over 66 markets, connecting businesses to users of 30 international payment partners. With travel picking up and tourism a key driver of many local economies, this enables many small businesses to connect with global mobile-first consumers in a simple, cost-efficient manner.
A key development in driving digitalization at scale is through Alipay+’s integration with national QRs. Alipay+ is currently integrated with the national QRs of Singapore, Malaysia and South Korea, which counts MSMEs as majority of its merchants. In Singapore, Alipay+ transactions at hawker stalls have increased 52% in H1 2024, compared to H2 2023. In Malaysia and South Korea, Alipay+ transactions increased 44% and 54% respectively via PayNet and ZeroPay, in Q2 vs Q1 2024. Alipay+ also has partnerships with national QRs in Cambodia, Nepal and Sri Lanka.
As a leading provider of digital payment solutions, Antom supports merchants of all sizes, including MSMEs, across over 40 countries and regions. Through a single integration, Antom connects them to more than 250 payment methods in over 150 markets. Its D-store solution enables MSME merchants to digitalize their operations and set up an online store in just 10 minutes with zero upfront cost. Over 5000 outlets have already onboarded this solution, with average monthly transactions growing by 27% in Q2 vs Q1 2024.
In supporting MSMEs to do business globally, WorldFirst empowers more than 1 million SMEs with international payments to 200+ markets in over 100 currencies. To enable more SMEs to do cross-border trade, WorldFirst will expand to more markets in Southeast Asia and Europe this year. ANEXT Bank, a digital wholesale bank incorporated in Singapore, recently celebrated its second anniversary, with two times year-on-year increase in its customer base, of which 69% are micro businesses. To further support regional MSMEs, ANEXT Bank has introduced its second batch of SME Friends of ANEXT with forward-thinking small and growing businesses to co-create the “digital bank of tomorrow”.
Ant International has also recently unveiled bettr, a new global digital lending service to provide micro lending to MSMEs through embedded finance partnerships, further accelerating financial inclusion.
Harnessing industry partnerships to drive MSME development
Ant International believes in open industry collaboration to jointly support knowledge and skills development for MSMEs.
In Indonesia, Ant International and DANA will launch the second edition of SisBerdaya, an initiative that provides female micro entrepreneurs training, mentoring, and educational programs in business management and digital skills. Started in 2023, the first edition drew more than 2700 applicants, with 180 participants undergoing a one-month training, and grants awarded to 30 entrepreneurs.
In collaboration with the International Finance Corporation, 10x1000 Tech for Inclusion is an open learning platform to help future digital leaders develop more skills to drive greater impact within their communities. As of 2023, with the support of 40+ global strategic partners, more than 6,000 individual talents from 100+ countries and regions completed the 10x1000 learning programs, of which 90% are from developing markets and 60% work in MSMEs.
Earlier this year, Ant International launched Programme Sirius, with the support of 13 Asia Pacific fintech leaders to empower MSMEs in their transition towards sustainability, in line with the United Nationals Sustainable Development Goals.
Global campaign to ‘Embrace the power of small’
In celebration of International MSME Day, Ant International launches its “Embrace the power of small” campaign featuring three business owners and their journeys of digitalization. The business owners are:
Cholthicha Joyyangsuk (Numwan), Thailand – a micro entrepreneur in Bangkok selling Thai desserts on her tuktuk. With Alipay+, she can now easily accept mobile payments from tourists, sharing a slice of culture, while giving her access to a wider pool of customers.
Lem Cheong, The Hainan Story, Singapore – inspired by his grandma’s rich heritage and flavourful recipes, Mr Cheong aims to evolves traditional dishes, just as he evolves his business with digital tools like Antom’s D-store solution to simplify his store operations.
Lewis Ames, Wrimes Cosmetics, UK – starting with neon face paint and pivoting to pet care during the pandemic, Mr Ames uses WorldFirst to pay his suppliers and collect payments from marketplaces easily, so he can grow his business from Stevenage to the world.
These stories will be featured on out-of-home billboards, starting in Europe, in time for the UEFA EURO 2024, of which Ant International is the Official Payment Partner, and rolled out to other global markets, and also on TV and social media.
About Ant International
Headquartered in Singapore, Ant International powers the future of global commerce with digital innovation for everyone and every business to thrive. In close collaboration with partners, we support merchants of all sizes worldwide to realize their growth aspirations through a comprehensive range of tech-driven digital payment and financial services solutions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240626356788/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release
The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom